Literature DB >> 29978438

Skull base versus non-skull base meningioma surgery in the elderly.

Torstein R Meling1,2, Michele Da Broi3, David Scheie4, Eirik Helseth3,5.   

Abstract

To compare outcomes after surgery for skull base meningiomas (SBMs) with non-skull base meningiomas (NSBMs) in the elderly. Overall, 128 consecutive patients ≥ 70 years of age with intracranial SBMs operated between 1990 and 2010 were compared to 193 consecutive patients ≥ 70 years of age with NSBMs operated within the same time period. Median age at surgery was 75.0 years (mean 75.7, range 70.0-92.4). Follow-up was complete with median 4.7 years (mean 5.5, range 0-19). The female-to-male ratio was 2.8 for SBMs and 1.3 for NSBMs (p < 0.005). The groups had similar preoperative KPS (median 80, range 20-100), but SBMs presented significantly more frequently with raised ICP (RR = 2.2, p < 0.005) and less frequently with seizures (RR = 0.6, p < 0.05). WHO I was significantly more frequent in SBMs (p < 0.005). Gross-total resection (GTR) was less frequent in SBMs (63 vs 82%) (RR = 2.1, p < 0.0001). SBMs were similar to NSBMs with respect to neurological outcome at 6-12 months, reoperations for hematomas, postoperative infections, and 30-day mortality. Retreatment rates and time to retreatments were also similar. There were no differences between the two groups with respect to risk of retreatment and overall survival (OS) at 5, 10, 15, and 20 years. In elderly patients with SBMs selected to surgical treatment, the risks of surgery, risk of retreatment, and OS were similar to NBSMs. Therefore, surgery for SBMs may be considered as safe as NSBMs in the elderly population.

Entities:  

Keywords:  Craniotomy; Intracranial tumor; Meningioma; Overall survival; Retreatment-free survival

Mesh:

Year:  2018        PMID: 29978438     DOI: 10.1007/s10143-018-1005-6

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  10 in total

1.  Management of incidental anterior skull base large and giant meningiomas in elderly patients.

Authors:  Yuqian Li; Dan Lu; Dayun Feng; Hongyu Cheng; Qian Huang; Haikang Zhao; Peng Chen; Huaizhou Qin; Qing Cai
Journal:  J Neurooncol       Date:  2020-06-11       Impact factor: 4.130

2.  WHO grade I meningiomas: classification-tree for prognostic factors of survival.

Authors:  Jean-Michel Lemée; Holger Joswig; Michele Da Broi; Marco Vincenzo Corniola; David Scheie; Karl Schaller; Eirik Helseth; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2019-06-10       Impact factor: 3.042

3.  Case Series of Skull Base Meningioma Resection in the Octogenarian Population.

Authors:  Dorian M Kusyk; Gordon Mao; Rocco Dabecco; Alexander K Yu
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

4.  Perioperative Complication Profile of Skull Base Meningioma Resection in Older versus Younger Adult Patients.

Authors:  Colin J Przybylowski; Kelly A Shaftel; Benjamin K Hendricks; Kristina M Chapple; Shawn M Stevens; Randall W Porter; Nader Sanai; Andrew S Little; Kaith K Almefty
Journal:  J Neurol Surg B Skull Base       Date:  2021-10-12

5.  Extent of Resection in Meningioma: Predictive Factors and Clinical Implications.

Authors:  Jean-Michel Lemée; Marco V Corniola; Michele Da Broi; Holger Joswig; David Scheie; Karl Schaller; Eirik Helseth; Torstein R Meling
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

6.  Management of Skull-Base Meningiomas With Extracranial Extensions: Clinical Features, Radiological Findings, Surgical Strategies, and Long-Term Outcomes.

Authors:  Wenbo He; Zhiyong Liu; Danyang Jie; Liansha Tang; Haibo Teng; Jianguo Xu
Journal:  Front Neurol       Date:  2022-07-01       Impact factor: 4.086

Review 7.  Management of Recurrent Meningiomas: State of the Art and Perspectives.

Authors:  Marco Vincenzo Corniola; Torstein R Meling
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

8.  Symptom burden and surgical outcome in non-skull base meningiomas.

Authors:  Tobias Mederer; Sebastian Schachinger; Katharina Rosengarth; Anja Brosig; Karl-Michael Schebesch; Christian Doenitz; Nils-Ole Schmidt; Martin Andreas Proescholdt
Journal:  Front Oncol       Date:  2022-09-21       Impact factor: 5.738

9.  Long-Term Clinical Outcome of First Recurrence Skull Base Meningiomas.

Authors:  Yuki Kuranari; Ryota Tamura; Noboru Tsuda; Kenzo Kosugi; Yukina Morimoto; Kazunari Yoshida; Masahiro Toda
Journal:  J Clin Med       Date:  2019-12-31       Impact factor: 4.241

Review 10.  Foramen magnum meningiomas: a systematic review and meta-analysis.

Authors:  Luca Paun; Renato Gondar; Paola Borrelli; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2021-01-28       Impact factor: 3.042

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.